A detailed history of Fora Capital, LLC transactions in Dyne Therapeutics, Inc. stock. As of the latest transaction made, Fora Capital, LLC holds 18,180 shares of DYN stock, worth $434,683. This represents 0.08% of its overall portfolio holdings.

Number of Shares
18,180
Previous 8,222 121.11%
Holding current value
$434,683
Previous $290,000 125.17%
% of portfolio
0.08%
Previous 0.04%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$31.94 - $47.04 $318,058 - $468,424
9,958 Added 121.11%
18,180 $653,000
Q2 2024

Aug 13, 2024

BUY
$23.65 - $35.63 $194,450 - $292,949
8,222 New
8,222 $290,000

Others Institutions Holding DYN

About Dyne Therapeutics, Inc.


  • Ticker DYN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 51,765,400
  • Market Cap $1.24B
  • Description
  • Dyne Therapeutics, Inc., a muscle disease company, operates as a biotechnology company that focuses on advancing therapeutics for genetically driven muscle diseases in the United States. It develops various programs for myotonic dystrophy type 1, duchenne muscular dystrophy, and facioscapulohumeral dystrophy, as well as rare skeletal muscle, and...
More about DYN
Track This Portfolio

Track Fora Capital, LLC Portfolio

Follow Fora Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fora Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fora Capital, LLC with notifications on news.